A pivotal role of activation of complement cascade (CC) in mobilization of hematopoietic stem/progenitor cells (HSPC).

[1]  M. Ratajczak,et al.  A Novel Role of Complement in Mobilization: Immunodeficient Mice Are Poor Granulocyte‐Colony Stimulating Factor Mobilizers Because They Lack Complement‐Activating Immunoglobulins , 2007, Stem cells.

[2]  S. Fukuda,et al.  The chemokine GRObeta mobilizes early hematopoietic stem cells characterized by enhanced homing and engraftment. , 2007, Blood.

[3]  M. Ratajczak,et al.  A hypothesis for an embryonic origin of pluripotent Oct-4+ stem cells in adult bone marrow and other tissues , 2007, Leukemia.

[4]  M. Ratajczak,et al.  Modulation of the SDF-1-CXCR4 axis by the third complement component (C3)--implications for trafficking of CXCR4+ stem cells. , 2006, Experimental hematology.

[5]  John D Lambris,et al.  Generation of C5a in the absence of C3: a new complement activation pathway , 2006, Nature Medicine.

[6]  John D Lambris,et al.  The role of third complement component (C3) in homing of hematopoietic stem/progenitor cells into bone marrow. , 2006, Advances in experimental medicine and biology.

[7]  D. Link,et al.  G-CSF potently inhibits osteoblast activity and CXCL12 mRNA expression in the bone marrow. , 2005, Blood.

[8]  O. Kollet,et al.  How do stem cells find their way home? , 2005, Blood.

[9]  M. Ratajczak,et al.  Trafficking of Normal Stem Cells and Metastasis of Cancer Stem Cells Involve Similar Mechanisms: Pivotal Role of the SDF‐1–CXCR4 Axis , 2005, Stem cells.

[10]  Christie M. Orschell,et al.  Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist , 2005, The Journal of experimental medicine.

[11]  M. Ratajczak,et al.  Transplantation studies in C3-deficient animals reveal a novel role of the third complement component (C3) in engraftment of bone marrow cells , 2004, Leukemia.

[12]  M. Ratajczak,et al.  Mobilization studies in mice deficient in either C 3 or C 3 a receptor ( C 3 aR ) reveal a novel role for complement in retention of hematopoietic stem / progenitor cells in bone marrow , 2003 .

[13]  T. Papayannopoulou.  Current mechanistic scenarios in hematopoietic stem/progenitor cell mobilization. , 2004, Blood.

[14]  M. Ratajczak,et al.  Stem cell plasticity revisited: CXCR4-positive cells expressing mRNA for early muscle, liver and neural cells ‘hide out’ in the bone marrow , 2004, Leukemia.

[15]  R. Willemze,et al.  Reduced stem cell mobilization in mice receiving antibiotic modulation of the intestinal flora: involvement of endotoxins as cofactors in mobilization. , 2004, Blood.

[16]  John D Lambris,et al.  Functional receptor for C3a anaphylatoxin is expressed by normal hematopoietic stem/progenitor cells, and C3a enhances their homing-related responses to SDF-1. , 2003, Blood.

[17]  J. Lévesque,et al.  Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide. , 2003, The Journal of clinical investigation.

[18]  M. Ratajczak,et al.  BTR2003: Unified Science & Technology for Reducing Biological Threats and Countering Terrorism March 19-21, 2003 Oral WGP Beta Glucan Treatment Accelerates Myeloid Recovery after Radiation Exposure , 2003 .

[19]  V. Jiménez‐Yuste,et al.  Induction of a hypercoagulability state and endothelial cell activation by granulocyte colony-stimulating factor in peripheral blood stem cell donors. , 2002, Journal of hematotherapy & stem cell research.

[20]  B. Williams,et al.  Mobilization by either cyclophosphamide or granulocyte colony-stimulating factor transforms the bone marrow into a highly proteolytic environment. , 2002, Experimental hematology.

[21]  P. Quesenberry,et al.  Stem cell homing: rolling, crawling, and nesting. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Jeffery L. Miller,et al.  Granulocyte colony-stimulating factor recruitment of CD34+ progenitors to peripheral blood : Impaired mobilization in chronic granulomatous disease and adenosine deaminase-deficient severe combined immunodeficiency disease patients , 1996 .